TERM ID="NYU_TERM_1" STRING="'-O-methoxyethyl-phosphorothioate" FREQUENCY=1 START=1251 END=1284 LEMMA="'-O-METHOXYETHYL-PHOSPHOROTHIOATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="Bcl-x SSO" FREQUENCY=3 START=1123 END=1132 LEMMA="BCL-X SSO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_3" STRING="Bcl-x SSO" FREQUENCY=3 START=1784 END=1793 LEMMA="BCL-X SSO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_4" STRING="Bcl-x SSO" FREQUENCY=3 START=2101 END=2110 LEMMA="BCL-X SSO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_5" STRING="Bcl-x SSO modified Bcl-x pre-mRNA splicing" FREQUENCY=1 START=1784 END=1826 LEMMA="MODIFIED BCL-X PRE-MRNA SPLICING BCL-X SSO" LEMMA_FREQUENCY=1 HEAD_TERM="modified Bcl-x pre-mRNA splicing" HEAD_LEMMA="MODIFIED BCL-X PRE-MRNA SPLICING"
TERM ID="NYU_TERM_6" STRING="Bcl-x gene" FREQUENCY=1 START=397 END=407 LEMMA="BCL-X GENE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="Bcl-x pre-mRNA" FREQUENCY=1 START=1212 END=1226 LEMMA="BCL-X PRE-MRNA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="Bcl-x pre-mRNA splicing" FREQUENCY=1 START=2055 END=2078 LEMMA="BCL-X PRE-MRNA SPLICING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="Bcl-xL" FREQUENCY=3 START=662 END=668 LEMMA="BCL-XL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_10" STRING="Bcl-xL" FREQUENCY=3 START=1021 END=1027 LEMMA="BCL-XL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_11" STRING="Bcl-xL" FREQUENCY=3 START=1645 END=1651 LEMMA="BCL-XL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_12" STRING="Bcl-xL expression" FREQUENCY=2 START=492 END=509 LEMMA="BCL-XL EXPRESSION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_13" STRING="Bcl-xL expression" FREQUENCY=2 START=1947 END=1964 LEMMA="BCL-XL EXPRESSION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_14" STRING="Bcl-xL mRNA" FREQUENCY=1 START=1707 END=1718 LEMMA="BCL-XL MRNA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="Bcl-xS" FREQUENCY=2 START=672 END=678 LEMMA="BCL-X" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_16" STRING="Bcl-xS" FREQUENCY=2 START=1655 END=1661 LEMMA="BCL-X" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_17" STRING="Pro-apoptotic effects" FREQUENCY=1 START=0 END=21 LEMMA="PRO-APOPTOTIC EFFECT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="RT-PCR" FREQUENCY=2 START=937 END=943 LEMMA="REAL TIME PCR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="RT-PCR" FREQUENCY=2 START=1678 END=1684 LEMMA="REAL TIME PCR" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_20" STRING="SSO" FREQUENCY=3 START=680 END=683 LEMMA="SSO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_21" STRING="SSO" FREQUENCY=3 START=811 END=814 LEMMA="SSO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_22" STRING="SSO" FREQUENCY=3 START=2038 END=2041 LEMMA="SSO" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_23" STRING="SSO exerted pro-apoptotic" FREQUENCY=1 START=680 END=705 LEMMA="EXERTED PRO-APOPTOTIC SSO" LEMMA_FREQUENCY=1 HEAD_TERM="exerted pro-apoptotic" HEAD_LEMMA="EXERTED PRO-APOPTOTIC"
TERM ID="NYU_TERM_24" STRING="SSO targeting Bcl-x pre-mRNA" FREQUENCY=1 START=811 END=839 LEMMA="TARGETING BCL-X PRE-MRNA SSO" LEMMA_FREQUENCY=1 HEAD_TERM="targeting Bcl-x pre-mRNA" HEAD_LEMMA="TARGETING BCL-X PRE-MRNA"
TERM ID="NYU_TERM_25" STRING="SSOs" FREQUENCY=3 START=258 END=262 LEMMA="SPLICE SWITCHING OLIGONUCLEOTIDES" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_26" STRING="SSOs" FREQUENCY=3 START=1392 END=1396 LEMMA="SPLICE SWITCHING OLIGONUCLEOTIDES" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_27" STRING="SSOs" FREQUENCY=3 START=1501 END=1505 LEMMA="SPLICE SWITCHING OLIGONUCLEOTIDES" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_28" STRING="Splice-switching oligonucleotides" FREQUENCY=1 START=223 END=256 LEMMA="SPLICE-SWITCHING OLIGONUCLEOTIDE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="U251" FREQUENCY=1 START=1058 END=1062 LEMMA="U251" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="U87" FREQUENCY=1 START=1050 END=1053 LEMMA="U87" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="aberrantly spliced human β-globin intron" FREQUENCY=1 START=1315 END=1355 LEMMA="ABERRANTLY SPLICED HUMAN Β-GLOBIN INTRON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="anti" FREQUENCY=1 START=444 END=448 LEMMA="ANTI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="antisense therapeutics" FREQUENCY=1 START=291 END=313 LEMMA="ANTISENSE THERAPEUTICS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="antitumor activity" FREQUENCY=1 START=2013 END=2031 LEMMA="ANTITUMOR ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="antitumor effects" FREQUENCY=1 START=1476 END=1493 LEMMA="ANTITUMOR EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="antitumor effects of the SSOs" FREQUENCY=1 START=1476 END=1505 LEMMA="SPLICE SWITCHING OLIGONUCLEOTIDES ANTITUMOR EFFECT" LEMMA_FREQUENCY=1 HEAD_TERM="antitumor effects" HEAD_LEMMA="ANTITUMOR EFFECT"
TERM ID="NYU_TERM_37" STRING="apoptosis" FREQUENCY=2 START=607 END=616 LEMMA="APOPTOSI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_38" STRING="apoptosis" FREQUENCY=2 START=1975 END=1984 LEMMA="APOPTOSI" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_39" STRING="apoptotic Bcl-xL" FREQUENCY=1 START=449 END=465 LEMMA="APOPTOTIC BCL-XL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="astrocyte cell lines" FREQUENCY=1 START=1450 END=1470 LEMMA="ASTROCYTE CELL LINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_41" STRING="cancer cell lines" FREQUENCY=1 START=746 END=763 LEMMA="CANCER CELL LINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="cancer cells" FREQUENCY=1 START=588 END=600 LEMMA="CANCER CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="cationic lipid" FREQUENCY=1 START=1419 END=1433 LEMMA="CATIONIC LIPID" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="chemosensitizing effects" FREQUENCY=1 START=710 END=734 LEMMA="CHEMOSENSITIZING EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="control SSO" FREQUENCY=1 START=1920 END=1931 LEMMA="CONTROL SSO" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="exerted pro-apoptotic" FREQUENCY=1 START=684 END=705 LEMMA="EXERTED PRO-APOPTOTIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="exon" FREQUENCY=1 START=1202 END=1206 LEMMA="EXON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_48" STRING="flow cytometry" FREQUENCY=1 START=1595 END=1609 LEMMA="FLOW CYTOMETRY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="glioma" FREQUENCY=1 START=1439 END=1445 LEMMA="GLIOMA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="glioma cell lines" FREQUENCY=6 START=93 END=110 LEMMA="GLIOMA CELL LINE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_51" STRING="glioma cell lines" FREQUENCY=6 START=849 END=866 LEMMA="GLIOMA CELL LINE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_52" STRING="glioma cell lines" FREQUENCY=6 START=1031 END=1048 LEMMA="GLIOMA CELL LINE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_53" STRING="glioma cell lines" FREQUENCY=6 START=1761 END=1778 LEMMA="GLIOMA CELL LINE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_54" STRING="glioma cell lines" FREQUENCY=6 START=1864 END=1881 LEMMA="GLIOMA CELL LINE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_55" STRING="glioma cell lines" FREQUENCY=6 START=2082 END=2099 LEMMA="GLIOMA CELL LINE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_56" STRING="including cancers" FREQUENCY=1 START=204 END=221 LEMMA="INCLUDING CANCER" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="lipid" FREQUENCY=1 START=1900 END=1905 LEMMA="LIPID" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="modified Bcl-x pre-mRNA splicing" FREQUENCY=1 START=1794 END=1826 LEMMA="MODIFIED BCL-X PRE-MRNA SPLICING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_59" STRING="near-ubiquitous phenomenon" FREQUENCY=1 START=137 END=163 LEMMA="NEAR-UBIQUITOUS PHENOMENON" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="negative control" FREQUENCY=1 START=1370 END=1386 LEMMA="NEGATIVE CONTROL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_61" STRING="normal human astrocyte cell line" FREQUENCY=1 START=1070 END=1102 LEMMA="NORMAL HUMAN ASTROCYTE CELL LINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_62" STRING="oligonucleotide" FREQUENCY=1 START=1289 END=1304 LEMMA="OLIGONUCLEOTIDE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_63" STRING="oligonucleotides" FREQUENCY=2 START=42 END=58 LEMMA="OLIGONUCLEOTIDE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_64" STRING="oligonucleotides" FREQUENCY=2 START=240 END=256 LEMMA="OLIGONUCLEOTIDE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_65" STRING="oligonucleotides targeting Bcl-x pre-mRNA" FREQUENCY=1 START=42 END=83 LEMMA="TARGETING BCL-X PRE-MRNA OLIGONUCLEOTIDE" LEMMA_FREQUENCY=1 HEAD_TERM="targeting Bcl-x pre-mRNA" HEAD_LEMMA="TARGETING BCL-X PRE-MRNA"
TERM ID="NYU_TERM_66" STRING="performed reverse transcription-polymerase chain reaction" FREQUENCY=1 START=878 END=935 LEMMA="PERFORMED REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_67" STRING="potential strategy" FREQUENCY=1 START=2120 END=2138 LEMMA="POTENTIAL STRATEGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_68" STRING="potential strategy for treating gliomas" FREQUENCY=1 START=2120 END=2159 LEMMA="TREATING GLIOMA POTENTIAL STRATEGY" LEMMA_FREQUENCY=1 HEAD_TERM="potential strategy" HEAD_LEMMA="POTENTIAL STRATEGY"
TERM ID="NYU_TERM_69" STRING="pre-mRNA splice site" FREQUENCY=1 START=371 END=391 LEMMA="PRE-MRNA SPLICE SITE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_70" STRING="pro-apoptotic Bcl-xS" FREQUENCY=1 START=470 END=490 LEMMA="PRO-APOPTOTIC BCL-X" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_71" STRING="pro-apoptotic effects" FREQUENCY=1 START=1835 END=1856 LEMMA="PRO-APOPTOTIC EFFECT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_72" STRING="protein" FREQUENCY=1 START=1723 END=1730 LEMMA="PROTEIN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_73" STRING="protein expression levels" FREQUENCY=1 START=992 END=1017 LEMMA="PROTEIN EXPRESSION LEVEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_74" STRING="protein expression levels of Bcl-xL" FREQUENCY=1 START=992 END=1027 LEMMA="BCL-XL PROTEIN EXPRESSION LEVEL" LEMMA_FREQUENCY=1 HEAD_TERM="protein expression levels" HEAD_LEMMA="PROTEIN EXPRESSION LEVEL"
TERM ID="NYU_TERM_75" STRING="redirecting Bcl-x pre-mRNA splicing" FREQUENCY=1 START=621 END=656 LEMMA="REDIRECTING BCL-X PRE-MRNA SPLICING" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_76" STRING="reverse transcription-polymerase chain reaction" FREQUENCY=1 START=888 END=935 LEMMA="REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_77" STRING="targeting Bcl-x pre-mRNA" FREQUENCY=2 START=59 END=83 LEMMA="TARGETING BCL-X PRE-MRNA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_78" STRING="targeting Bcl-x pre-mRNA" FREQUENCY=2 START=815 END=839 LEMMA="TARGETING BCL-X PRE-MRNA" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_79" STRING="treating gliomas" FREQUENCY=1 START=2143 END=2159 LEMMA="TREATING GLIOMA" LEMMA_FREQUENCY=1
